Related Experiment Video
Updated: Jun 21, 2026

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
Published on: May 4, 2018
Release of antihypertensive peptides in miso paste during its fermentation, by the addition of casein
Kaori Inoue1, Takanobu Gotou, Hirokuni Kitajima
1Functional Food and Drink Development Laboratory, Calpis Co., Ltd., 11-10 5-Chome, Fuchinobe, Sagamihara-shi, Kanagawa 229-0006, Japan.
Abstract:
Casein hydrolysate by Aspergillus oryzae protease has been developed to obtain two kinds of antihypertensive peptides, Val-Pro-Pro and Ile-Pro-Pro. In this study, casein miso paste was prepared by adding casein at various concentrations during miso paste fermentation in order to release angiotensin-I converting enzyme (ACE) inhibitory peptides. Increase of peptide concentration and ACE inhibitory activity in casein miso paste was observed and corresponded to the degradation of casein and soy bean proteins during fermentation for 7 days. ACE inhibitory activity of the casein miso paste was higher than that of the general (casein-free) miso paste after fermentation for 7 days. The levels of ACE inhibitory peptides, Val-Pro-Pro and Ile-Pro-Pro, were increased in the casein miso paste during the fermentation. Significant antihypertensive effects of casein miso paste compared to water and the general miso paste (P<0.05 and P<0.05) were confirmed in spontaneously hypertensive rats at a dosage of 1.8 g of the casein miso paste/kg of BW. Taken into account of minimum effective dosages of Val-Pro-Pro and Ile-Pro-Pro in previous clinical studies, these results suggest that casein miso paste might have the potential to control blood pressure in humans.
Insights
Casein miso paste, enriched with antihypertensive peptides Val-Pro-Pro and Ile-Pro-Pro, demonstrated significant blood pressure-lowering effects in hypertensive rats. This suggests potential for casein miso paste in human blood pressure management.
Area of Science:
- Food Science and Technology
- Biochemistry
- Nutraceuticals
Background:
- Antihypertensive peptides are derived from protein hydrolysis.
- Angiotensin-I converting enzyme (ACE) inhibitors play a role in blood pressure regulation.
- Miso paste fermentation offers a potential vehicle for bioactive peptide delivery.
Purpose of the Study:
- To develop casein miso paste with enhanced ACE inhibitory activity.
- To investigate the release of specific antihypertensive peptides (Val-Pro-Pro, Ile-Pro-Pro) during fermentation.
- To evaluate the in vivo antihypertensive effects of casein miso paste.
Main Methods:
- Casein was added during miso paste fermentation.
- Protein degradation and ACE inhibitory activity were monitored over 7 days.
- Levels of Val-Pro-Pro and Ile-Pro-Pro were quantified.
- Antihypertensive effects were assessed in spontaneously hypertensive rats.
Main Results:
- Casein miso paste showed increased peptide concentration and ACE inhibitory activity compared to regular miso paste.
- Fermentation for 7 days led to the release of Val-Pro-Pro and Ile-Pro-Pro.
- Casein miso paste significantly reduced blood pressure in rats compared to controls.
- The antihypertensive effect was observed at a dosage of 1.8 g/kg body weight.
Conclusions:
- Casein miso paste fermentation effectively produces antihypertensive peptides.
- Casein miso paste exhibits significant antihypertensive properties in a rat model.
- These findings suggest casein miso paste's potential as a functional food for blood pressure control in humans.
Related Concept Videos
Microbes in the Production of Fermented Foods
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Direct Renin Inhibitors
Hormonal Regulation
Hormonal Regulation
Antihypertensive Drugs: Action of Calcium Channel Blockers

